One in about 7 Americans said they have personally used cannabidiol (CBD) based products, which have doubled since last year’s passage of a federal law authorizing this hemp form of cannabis (marijuana). Young Americans and those in the Western part of the U.S. are more likely to report utilizing these products, which are used for their therapeutic advantages without any psychoactive effects because they include a low level of THC.
Although cannabidiol (CBD) was legalized federally last December, the FDA is still researching it, and some states are still restricting it. While 14% of U.S. adults are using Cannabidiol (CBD) products, Gallup’s June 19-July 12 polling found that 50% do not use them and 35% are not at all familiar with them. (Those who do not have any familiarity with Cannabidiol (CBD) products were not asked about their personal usage of them.)
Twenty percent of adults younger than 30 say they use Cannabidiol (CBD), but usage and familiarity decrease progressively in older age groups. Just 8% of those aged 65 and older say they use Cannabidiol (CBD), and 49% are not familiar with it. This same pattern is evident in Gallup’s data on marijuana usage, with younger adults reporting a higher prevalence of marijuana use than is true for older adults.
Regionally, 21% of those in the Western U.S. use Cannabidiol (CBD) products, compared with 13% in the South, and 11% in both the East and Midwest. Marijuana use is legal in many Western states, and Cannabidiol (CBD) products have therefore been available for a longer time to residents of those states.
Why Cannabidiol (CBD) Users Utilize It
While the FDA is still researching the uses and effectiveness of Cannabidiol (CBD) products, marketers claim they have a wide variety of medical and therapeutic benefits. Cannabidiol (CBD) users in the U.S. cite insomnia (11%), anxiety (20%), relief from pain (40%), and arthritis (8%) as the best reasons for use.
Among men and women who use Cannabidiol (CBD) products, roughly four in 10 of each say they use them for pain relief; but women are more likely than men to use them for anxiety (25% vs. 14%, respectively), and men are more likely than women to use them for help in sleeping (15% vs. 8%).
Since the 2018 Farm Act legalizing the cultivation of hemp was signed into law last December, many Cannabidiol (CBD)-based products have hit the market, but the large majority of Americans are not yet familiar with them or don’t use them. Those who say they use them do so primarily to treat pain, anxiety and sleeplessness.
Older Americans are less familiar with Cannabidiol (CBD) products and less likely to be using them now. As the FDA begins to regulate Cannabidiol (CBD) products and if they become more mainstream, older Americans may stand to benefit the most from them for the treatment of the aches and pains that come with age.